The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMID 18179935)

Published in J Thorac Cardiovasc Surg on November 12, 2007

Authors

Benjamin D Kozower1, Bryan F Meyers, Michael A Smith, Nilto C De Oliveira, Stephen D Cassivi, Tracey J Guthrie, Honkung Wang, Beverly J Ryan, K Robert Shen, Thomas M Daniel, David R Jones

Author Affiliations

1: Department of Surgery, University of Virginia Health System, Charlottesville 22908-0679, USA. bdk8g@virginia.edu

Articles citing this

Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19

The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.72

An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med (2013) 1.66

Impact of the lung allocation score on survival beyond 1 year. Am J Transplant (2014) 1.57

Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med (2015) 1.45

Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant (2013) 1.42

High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22

Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant (2010) 1.09

Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg (2009) 0.86

The lung allocation score and survival in lung transplant candidates with chronic obstructive pulmonary disease. Lung (2009) 0.86

An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol (2010) 0.82

Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant (2012) 0.79

Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients. J Heart Lung Transplant (2015) 0.78

Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. J Thorac Cardiovasc Surg (2011) 0.76

Lung Transplantation in Patients with High Lung Allocation Scores in the US: Evidence for the Need to Evaluate Score Specific Outcomes. J Transplant (2015) 0.75

Gas Transfer in Cellularized Collagen-Membrane Gas Exchange Devices. Tissue Eng Part A (2015) 0.75

Successful lung transplant from donor after cardiac death: a potential solution to shortage of thoracic organs. Mayo Clin Proc (2010) 0.75

The corneal transplant score: a simple corneal graft candidate calculator. Graefes Arch Clin Exp Ophthalmol (2013) 0.75

Articles by these authors

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J (2004) 11.00

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94

Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg (2011) 5.14

Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther (2003) 3.71

The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell (2003) 3.36

To RCT or not to RCT: deciding when 'more evidence is needed' for public health policy and practice. J Epidemiol Community Health (2011) 3.26

Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg (2011) 3.08

How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95

Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol (2008) 2.93

Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma? Ann Thorac Surg (2012) 2.86

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69

Solitary fibrous tumors of the pleura: results of surgical treatment and long-term prognosis. J Thorac Cardiovasc Surg (2009) 2.33

Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg (2010) 2.31

Monitoring mortality rates in general practice after Shipman. BMJ (2003) 2.26

STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg (2010) 2.25

Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration. Ann Thorac Surg (2010) 2.25

A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B (2006) 2.23

Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg (2007) 2.22

Pathologic lymph node ratio is a predictor of survival in esophageal cancer. Ann Thorac Surg (2012) 2.20

Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg (2013) 2.16

Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg (2009) 2.10

Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2010) 2.06

Ten-year experience on 644 patients undergoing single-port (uniportal) video-assisted thoracoscopic surgery. Ann Thorac Surg (2013) 2.01

Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00

Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg (2007) 1.99

"Corkscrew stenosis": defining and preventing a complication of percutaneous dilatational tracheostomy. J Thorac Cardiovasc Surg (2013) 1.97

Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94

Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93

Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. Lancet (2002) 1.91

Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91

Finding qualitative research: an evaluation of search strategies. BMC Med Res Methodol (2004) 1.89

Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther (2004) 1.89

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest (2005) 1.89

Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 1.86

Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med (2007) 1.83

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. Ann Thorac Surg (2006) 1.81

Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80

Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol (2012) 1.74

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem (2003) 1.73

A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med (2003) 1.72

Chest-wall desmoid tumors: results of surgical intervention. Ann Thorac Surg (2004) 1.70

Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell (2007) 1.70

Primary payer status affects mortality for major surgical operations. Ann Surg (2010) 1.69

Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol (2006) 1.68

Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg (2004) 1.67

Comparative analysis of showering protocols for mass-casualty decontamination. Prehosp Disaster Med (2010) 1.62

Methodology and reporting of systematic reviews and meta-analyses of observational studies in psychiatric epidemiology: systematic review. Br J Psychiatry (2012) 1.60

Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59

Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol (2008) 1.58

N2 disease in T1 non-small cell lung cancer. Ann Thorac Surg (2009) 1.58

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer (2005) 1.55

Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54

Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases. J Thorac Cardiovasc Surg (2012) 1.54

Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg (2011) 1.52

Does surgeon workload per day affect outcomes after pulmonary lobectomies? Ann Thorac Surg (2012) 1.52

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos (2002) 1.52

Benign esophageal tumors: introduction, incidence, classification, and clinical features. Semin Thorac Cardiovasc Surg (2003) 1.51

EUS-FNA as the initial diagnostic modality in centrally located primary lung cancers. J Clin Gastroenterol (2007) 1.51

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg (2009) 1.51

A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest (2003) 1.51

Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation. Drug Metab Dispos (2010) 1.50

The variability of practice in minimally invasive thoracic surgery for pulmonary resections. Thorac Surg Clin (2008) 1.50

Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50

Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review. BMJ (2002) 1.50

Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg (2008) 1.50

Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.50

Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer (2007) 1.50

Hiatal hernia after esophagectomy: analysis of 2,182 esophagectomies from a single institution. Ann Thorac Surg (2011) 1.49

Radial artery grafts in women: utilization and results. Ann Thorac Surg (2005) 1.48

A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res (2004) 1.47

Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg (2006) 1.46

Intraoperative factors and the risk of respiratory complications after pneumonectomy. Ann Thorac Surg (2011) 1.45

Visualization of PtdIns3P dynamics in living plant cells. Plant J (2006) 1.44

Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy. Ann Thorac Surg (2012) 1.43

A novel technique for localization and excisional biopsy of small or ill-defined pulmonary lesions. Ann Thorac Surg (2004) 1.43

The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg (2007) 1.43

Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg (2007) 1.42

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41

Economic assessment of the general thoracic surgery outpatient service. Ann Thorac Surg (2006) 1.41

Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med (2007) 1.40

Choosing wisely: cardiothoracic surgeons partnering with patients to make good health care decisions. Ann Thorac Surg (2013) 1.40